Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AUR vs GSK✓SelectedUSD · GSKAUR vs GSK performance historyLatest closeAs of-1.54%11/19
Stock and ETF performance explorer

AUR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+73.0%
GSK return
+53.5%
Excess return
+19.4%
Maximum drawdown
-63.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%0.0%-1.4%
7D-11.7%-4.7%-7.0%-11.3%
30D-23.4%-4.7%-18.7%-23.0%
3M-38.0%-8.8%-29.3%-37.4%
6M-44.7%-4.6%-40.0%-44.5%
YTD0.0%+1.0%-1.0%-0.9%
1Y+0.3%+6.9%-6.6%-1.5%
All+73.0%+53.5%+19.4%+79.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling